Navigation Links
ADVENTRX Announces Appointment Of Chief Medical Officer
Date:8/14/2012

from the University of Maryland and completed a residency in internal medicine at the Baylor College of Medicine. 

"I have been closely involved in the development and lifecycle management of several transformative products, including Lovenox®, Cubicin®, Xarelto®, and Natrecor®, and I look forward to playing a key role in successful development of ANX-188, which has the potential to treat many serious and life-threatening diseases and conditions," said Dr. Vetticaden. "With the phase 3 study in sickle cell disease anticipated to begin this year, joining ADVENTRX is an opportunity to have a potentially transformational impact in the treatment of diseases and conditions associated with microvascular dysfunction."

"Dr. Vetticaden brings to ADVENTRX decades of drug development and clinical experience as well as valuable clinical pharmacology and translational expertise," stated Brian M. Culley, Chief Executive Officer of ADVENTRX. "He has a proven track record of advancing innovative therapies through all stages of the product lifecycle and is a welcome addition to our senior management team as we advance ANX-188 into a phase 3 study."

About ADVENTRX Pharmaceuticals
ADVENTRX Pharmaceuticals is a biopharmaceutical company developing proprietary product candidates to treat various diseases and conditions. The Company's lead product candidate, ANX-188, has potential to reduce ischemic tissue injury and end-organ damage by restoring microvascular function which is compromised  in a wide range of serious and life-threatening diseases and conditions.  The Company initially is developing ANX-188 as a treatment for complications arising from sickle cell disease. More information can be found on the Company's web site at www.adventrx.com.

Forward Looking Statements
ADVENTRX cautions you that statements included in this press release that are not a description of histo
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ADVENTRX Pharmaceuticals to Present at 1st Annual Sickle Cell Disease Therapeutics Conference
2. ADVENTRX Applauds Inclusion of Rare Diseases Provisions in the FDA Safety and Innovation Act
3. ADVENTRX Pharmaceuticals To Present At The OneMedForum New York 2012 Emerging Company Finance Conference On July 12
4. ADVENTRX Announces Manufacturing Agreement With Patheon to Manufacture ANX-188 Drug Product
5. ADVENTRX Pharmaceuticals To Present At 2012 BIO International Convention Business Forum
6. FDAnews Announces Medical Device Mobile Apps Virtual Conference
7. Dehaier Medical Announces 2012 Second Quarter and Six Month Financial Results
8. Isis Pharmaceuticals Announces Redemption Of 2 5/8% Convertible Subordinated Notes Due 2027
9. WuXi PharmaTech Announces Second-Quarter 2012 Results
10. Varian Medical Systems CEO Timothy E. Guertin Announces Plans to Retire; Board of Directors Names Dow R. Wilson as Successor
11. Comprehensive Care Corporation Announces Profitable Six Month Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 2014  Depomed, Inc. (NASDAQ: DEPO ) ... year 2014 financial results after the market closes on Wednesday, ... call beginning at 4:30 pm EDT, 1:30 pm PDT to discuss ... by dialing 877-317-6789 ( United States ) ... available via a live webcast on the investor relations ...
(Date:7/25/2014)... July 25, 2014 /PRNewswire-iReach/ -- ScriptPro, of ... Powers Lake, Wisconsin , announce ... distribution and co-marketing agreement allowing ScriptPro to bring ... the United States . ScriptPro ... and workflow systems to retail and ambulatory pharmacies. ...
(Date:7/25/2014)... -- CVS Caremark Corporation (NYSE: CVS ) will ... 2014, at 8:30 a.m. (EDT) with analysts and investors ... An audio webcast of the conference call will ... the CVS Caremark website for all interested parties.  To ... will be archived and available on the web site ...
Breaking Medicine Technology:Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3
... Mylan Inc. (Nasdaq: www.mylan.com . ... release includes statements that constitute "forward-looking statements." These statements ... the Private Securities Litigation Reform Act of 1995. Because ... results may differ materially from those expressed or implied ...
... 6 Endo Pharmaceuticals (Nasdaq: ENDP ) today ... Specialty Pharmaceuticals Conference on Thursday, August 12, 2010 , at 8:00 ... Endo, will review the company,s products and development programs. , ... The presentation will be webcast live and can ...
Cached Medicine Technology:Endo to Present at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference 2
(Date:7/25/2014)... The Little Gym of Houston will attend the ... at Discovery Green in downtown Houston. The eleven ... Spring, The Woodlands, Sugarland-Missouri City, Kingwood, Bellaire and their ... to be attending and performing at the Family Fun ... Sugarland-Missouri City location. “We believe in the message and ...
(Date:7/25/2014)... 25, 2014 AttorneyOne.com, a recognized authority on ... from the FDA on Ibuprofen and Oxcarbazepine Tablets . ... lot of Ibuprofen and one lot of Oxcarbazepine Tablets, by ... mislabeled packaging. Oxcarbazepine is used for the treatment of certain ... The reason for the recall is that Lot #142588, Expiration ...
(Date:7/25/2014)... Ticket Down is a reliable source for cheap ... California Memorial Stadium. With the post-World Cup emotions still rolling ... the 2014 Guinness International Champions Cup have brought eight of ... representing La Liga, English Premier League, Serie A, and Superleague ... players from around the world to 12 American cities and ...
(Date:7/25/2014)... AZ (PRWEB) July 25, 2014 ... , a Nuanced Media client and the nation’s ... and dental employee handbooks, announced their partnership with ... TransAct is a registered ISO/MSP of Chase Paymentech ... the transaction processing industry. Companies that are members ...
(Date:7/25/2014)... 25, 2014 Hastings and Hastings, ... attorney’s fees with regard to personal injury claims, announces ... wide range of legal services for those that have ... another individual or corporation. Free initial consultation services gives ... of a potential personal injury claim . It ...
Breaking Medicine News(10 mins):Health News:The Little Gym of Houston to Attend Houston Family Magazine’s Family Fun Fest 2014 2Health News:Ibuprofen and Oxcarbazepine Tablets Recalled: AttorneyOne Monitors and Keep Consumers Informed 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 3Health News:Nuanced Media Client, CEDR HR Solutions, Partners with TransAct to Serve Medical, Dental, and Eye Care Professionals 2Health News:Hastings and Hastings Announces Complimentary Consultation Services 2Health News:Hastings and Hastings Announces Complimentary Consultation Services 3
... May 13 /Xinhua-PRNewswire-FirstCall/ -- China Sky One,Medical, Inc. ... of pharmaceutical, medicinal and diagnostic products in China,today ... at 5:00 p.m. Eastern,Time on May 15, 2008 ... Joining Mr. Yan-qing Liu, Chairman, CEO and ...
... blood-pressure drugs given in the study were probably too high ... the blood pressure-lowering drugs known as beta blockers after having ... a stroke, a new Canadian study found. , However, the ... heart attack, according to the report in the May 13 ...
... 13 Paramed Systems today announced,the release and first ... fully motorized stair climbing chair to oil and,gas platform ... the MOV chair on,drilling platforms will enable the safe ... platform., Paramed developed the dual-track MOV in response ...
... Calif., May 13 TorreyPines Therapeutics, Inc.,(Nasdaq: TPTX ... first quarter ended March 31, 2008. For the three-month ... net loss of $3.9 million. Cash,and cash equivalents totaled ... been diligently executing on the strategic plan outlined in,February, ...
... Calif., May 13 Visage Imaging,Inc., a wholly ... announced it was selected by Tufts Medical Center, ... system with the fully integrated,Visage Cardiac Analysis Package. ... offering outstanding patient care, teaching,generations of future physicians ...
... platform updates and product road map for developers., ... take the next step toward increasing patient safety ... Microsoft Health Common User,Interface (CUI), available today from ... toolkit controls and showcase demonstrators,the Microsoft Health CUI ...
Cached Medicine News:Health News:China Sky One Medical, Inc. Announces Conference Call to Discuss First Quarter 2008 Results 2Health News:Beta Blockers Raise Stroke, Death Risk After Surgery 2Health News:Beta Blockers Raise Stroke, Death Risk After Surgery 3Health News:TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 2Health News:TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 3Health News:TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 4Health News:TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 5Health News:TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 6Health News:TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 7Health News:Visage Imaging to Provide Fully Integrated Thin Client-Based Solution to Tufts Medical Center 2Health News:Visage Imaging to Provide Fully Integrated Thin Client-Based Solution to Tufts Medical Center 3Health News:Updated Microsoft Health Common User Interface Furthers Clinical Effectiveness, Increases Patient Safety 2Health News:Updated Microsoft Health Common User Interface Furthers Clinical Effectiveness, Increases Patient Safety 3
The PYRAMETRIX PLUS instrument system is the next generation in design for disc space preparation and removal....
Kerrison (Spurling) Laminectomy Rongeur. 15 cm - 6, thick footplate, large handle, 90 up-cutting, 2 mm wide....
Schlesinger Laminectomie Rongeur, golden springs. 15 cm - 6, with narrow footplate, large handle, 40 down-cutting, jaws 3 mm wide....
Kerrison (Micro) Laminectomy rongeur with ejector. 18 cm - 7 1/8, thick footplate, small handle, very delicate, 40 up-cutting, jaws 2 mm wide....
Medicine Products: